⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Eloxx Pharmaceuticals, Inc. Common Stock

$16.57
+0.26 (+1.56%)

Volume:

29.54K ($488.31K)

Market Capitalization:

$66.88M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Eloxx Pharmaceuticals Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$16.57
Close$16.57
Low$16.57
Low Change0.00 (0.00%)
High$16.57
High Change+0.00 (+0.00%)
Range$0.00
Volume252
Dollar Volume$4.18K

Regular Trading Hours

+0.50(+3.12%)
Open$16.03
Close$16.53
Low$15.16
Low Change-0.87 (-5.43%)
High$17.74
High Change+1.71 (+10.67%)
Range$2.58
Volume29.288K
Dollar Volume$484.13K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$16.17
Close$16.17
Low$16.17
Low Change0.00 (0.00%)
High$16.17
High Change+0.00 (+0.00%)
Range$0.00
Volume698
Dollar Volume$11.29K

Regular Trading Hours Yesterday

+0.83(+5.33%)
Open$15.49
Close$16.32
Low$15.00
Low Change-0.49 (-3.16%)
High$17.42
High Change+1.93 (+12.46%)
Range$2.42
Volume17.403K
Dollar Volume$283.93K

Premarket Yesterday

*No Trades in Segment

Eloxx Pharmaceuticals News

There is no current news for this stock at the moment.

Eloxx Pharmaceuticals Top Trades

Eloxx Pharmaceuticals's top trade so far today returned +10.67%, while the top short trade returned -6.82%.

Eloxx Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$15.29
10 Day Moving Average (SMA10)$16.28
20 Day Moving Average (SMA20)$17.59
50 Day Moving Average (SMA50)$15.15
100 Day Moving Average (SMA100)
200 Day Moving Average (SMA200)

Eloxx Pharmaceuticals Statistics

Average Volume (30 Days)46.06K
P/E Ratio (Current)-3.92
EPS (Current)-$4.12
Dividend Yield0.00%
Free Cash Flow
Cash Ratio0.05
Current Ratio0.07
Quick Ratio0.07
Debt to Equity-0.17
Enterprise Value$58.31M
EV to EBITDA-4.59
EV to Sales
Price to Book-2.46
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-8.27%
Return on Equity0.63%

Eloxx Pharmaceuticals Stock Splits

There have been 2 stock splits for Eloxx Pharmaceuticals (ELOX). The last reverse stock split occured on June 1, 2026 and reduced the outstanding shares at a ratio of 11:1.

DateTypeRatio
Jun 1, 2026Reverse11:1
Dec 2, 2022Reverse40:1

Eloxx Pharmaceuticals Dividends

There have been no dividends for Eloxx Pharmaceuticals (ELOX).